Le Lézard
Classified in: Health, Business

Concord Medical Files 2023 Annual Report on Form 20-F


BEIJING, April 19, 2024 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov. Shareholders may receive a hard copy of the Annual Report free of charge upon request. Requests should be submitted to http://ir.ccm.cn.

About Concord Medical

Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China. For more information, please see http://ir.ccm.cn.

Safe Harbor Statement

This announcement contains forward-looking statements. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar expressions. Forward-looking statements are inherently subject to uncertainties and contingencies beyond the Company's control and based upon premises with respect to future business decisions, which are subject to change. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

SOURCE Concord Medical Services Holdings Limited


These press releases may also interest you

at 15:30
Donaldson Company, Inc. , a leading worldwide provider of innovative filtration products and solutions, today announced that Scott Robinson, chief financial officer will present at the Oppenheimer 19th Annual Industrial Growth Conference on Monday,...

at 15:30
Ephicacy Consulting Group, Inc. ("Ephicacy"), a leading biometrics Contract Research Organization ("CRO"), today announced that it has acquired Advance Research Associates ("ARA"), a provider of data management and biostatistical consulting services...

at 15:27
Three Ontario nurses will be recognized during National Nursing Week (May 6 ? 12, 2024) for their extraordinary contributions to the nursing profession and Ontario's health system as part of the annual Nursing Now Ontario Awards (NNOA). The...

at 15:09
eHealth Technologies, a leading healthcare technology company that advances the delivery of life-altering care, has been named by Newsweek as one of World's Best Digital Health Companies in medical record management. Newsweek's inaugural ranking of...

at 15:02
The Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) has issued a new guidance document that provides expert recommendations on fundamental areas of clinical testing for respiratory viral infections. As respiratory virus...

at 14:52
3CHI is proud to announce the successful conclusion of a detailed tolerability and safety assessment of its Platinum Delta 8 THC oil, conducted in collaboration with Hera Biolabs. This pivotal study further confirms the safety of Delta 8 THC and...



News published on and distributed by: